Stay on top of the latest research and practice
A: All accepted abstracts are scheduled in the scientific programme either as oral or poster presentations.
It is expected that at least one author of the abstract attends the Congress to present the work and answer questions. Only abstracts of registered participants will be scheduled in the scientific programme.
A: All abstracts can only be submitted via the online form until Dec 11, 2023, 24:00 CEST.
View the submission guidelines and find out more on how to submit your abstract.
For any questions on your submitted abstract please contact the ESGO Office.
A: Yes. A presenting author can submit up to 3 abstracts.
However, please do not submit the same abstract for an oral and a poster presentation.
A: Yes. The number of authors per abstract is limited to 20.
A: Only after all abstracts have been reviewed by the scientific committee will notifications be sent to the abstract submitters.
Every effort is made to conclude this process within a month after the abstract submission deadline, by January 15, 2024.
A: You may enter the abstract submission system with your username and password and make changes to your abstract until the submission deadline date.
No abstract changes will be accepted after this date. Updated information may be presented in the poster presentation.
A: Yes. All accepted abstracts will be published in an online supplement to the International Journal of Gynaecological Cancer.
A: Late-breaking abstracts (LBA) can only be submitted via the online form.
The initial LBA must be submitted until December 11, 2023 as a placeholder (shell) abstract submission and completed during January 8-22, 2024 during the LBA final data submission period. View submission guidelines.
A: LBA will not be accepted at a later date unless a shell abstract has been submitted by the submission deadline on June 27, 2022.
If you have read the above and your question is not answered do not hesitate to contact us.